Stomatology ›› 2024, Vol. 44 ›› Issue (1): 63-68.doi: 10.13591/j.cnki.kqyx.2024.01.014
• Review • Previous Articles Next Articles
HOU Zhengyao1,WANG Kexin2,WANG Qingmei2,YANG Xiaochen2(),SONG Kai2(
)
Received:
2023-05-08
Online:
2024-01-28
Published:
2024-01-22
CLC Number:
HOU Zhengyao, WANG Kexin, WANG Qingmei, YANG Xiaochen, SONG Kai. Current research status of oral human papillomavirus(HPV) infection[J]. Stomatology, 2024, 44(1): 63-68.
[1] | 王建彬, 魏然, 梁春梅, 等. 异性恋男性口腔、生殖器人乳头瘤病毒感染及对性伴传播的影响[J]. 实用皮肤病学杂志, 2020, 13(2):92-94, 97. |
[2] |
Zhu S, Chang J, Hayat K, et al. Parental preferences for HPV vaccination in junior middle school girls in China:A discrete choice experiment[J]. Vaccine, 2020, 38(52):8310-8317.
doi: 10.1016/j.vaccine.2020.11.020 |
[3] | Wang D, Wu J, Du JS, et al. Acceptability of and barriers to human papillomavirus vaccination in China:A systematic review of the Chinese and English scientific literature[J]. Eur J Cancer Care, 2022, 31(3):e13566. |
[4] | 成媛媛, 石梅, 钱伊弘, 等. 上海地区男男性行为者肛门部位尖锐湿疣HPV型别特征及口腔部位HPV感染情况研究[J]. 中国男科学杂志, 2017, 31(2):22-28. |
[5] |
He JY, Li TJ, Wang YL, et al. Genetic variability of human papillomavirus type 39 based on E6, E7 and L1 genes in Southwest China[J]. Virol J, 2021, 18(1):72.
doi: 10.1186/s12985-021-01528-w pmid: 33832494 |
[6] |
Pešut E -Dukić A, Lulić L, et al. Human papillomaviruses-associated cancers:An update of current knowledge[J]. Viruses, 2021, 13(11):2234.
doi: 10.3390/v13112234 |
[7] | Radzki D, Kusiak A, Ordyniec-Kwaśnica I, et al. Human papillomavirus and leukoplakia of the oral cavity:A systematic review[J]. Postepy Dermatol Alergol, 2022, 39(3):594-600. |
[8] |
Galati L, Chiocca S, Duca D, et al. HPV and head and neck cancers:Towards early diagnosis and prevention[J]. Tumour Virus Res, 2022, 14:200245.
doi: 10.1016/j.tvr.2022.200245 |
[9] |
Betz SJ. HPV-related papillary lesions of the oral mucosa:A review[J]. Head Neck Pathol, 2019, 13(1):80-90.
doi: 10.1007/s12105-019-01003-7 |
[10] |
Tam S, Fu SS, Xu L, et al. The epidemiology of oral human papillomavirus infection in healthy populations:A systematic review and meta-analysis[J]. Oral Oncol, 2018, 82:91-99.
doi: 10.1016/j.oraloncology.2018.04.005 |
[11] |
Liu FF, Hang D, Deng QJ, et al. Concurrence of oral and genital human papillomavirus infection in healthy men:A population-based cross-sectional study in rural China[J]. Sci Rep, 2015, 5:15637.
doi: 10.1038/srep15637 |
[12] |
Di Spirito F, Pantaleo G, Di Palo MP, et al. Oral human papillomavirus benign lesions and HPV-related cancer in healthy children:A systematic review[J]. Cancers, 2023, 15(4):1096.
doi: 10.3390/cancers15041096 |
[13] |
Alramadhan SA, Fitzpatrick SG, Bhattacharyya I, et al. Changing trends in benign human papillomavirus (HPV) related epithelial neoplasms of the oral cavity:1995-2015[J]. Head Neck Pathol, 2022, 16(3):738-745.
doi: 10.1007/s12105-022-01426-9 pmid: 35257322 |
[14] | Piña AR, Fonseca FP, Pontes FSC, et al. Benign epithelial oral lesions - association with human papillomavirus[J]. Med Oral Patol Oral Cir Bucal, 2019, 24(3):e290-e295. |
[15] |
de la Cour CD, Sperling CD, Belmonte F, et al. Human papillomavirus prevalence in oral potentially malignant disorders:Systematic review and meta-analysis[J]. Oral Dis, 2021, 27(3):431-438.
doi: 10.1111/odi.v27.3 |
[16] |
Christianto S, Li KY, Huang TH, et al. The prognostic value of human Papilloma virus infection in oral cavity squamous cell carcinoma:A meta-analysis[J]. Laryngoscope, 2022, 132(9):1760-1770.
doi: 10.1002/lary.v132.9 |
[17] |
Chan JYK, Cheung MK, Lan LL, et al. Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes[J]. Oral Oncol, 2022, 135:106245.
doi: 10.1016/j.oraloncology.2022.106245 |
[18] | Huang KS, Ni GY, Ma BW, et al. Importance of human papillomavirus infection in squamous cell carcinomas of the tongue in Guangdong Province, China[J]. J Int Med Res, 2020, 48(1):300060519897187. |
[19] |
Ni GY, Huang KS, Luan Y, et al. Human papillomavirus infection among head and neck squamous cell carcinomas in Southern China[J]. PLoS One, 2019, 14(9):e0221045.
doi: 10.1371/journal.pone.0221045 |
[20] |
Bukhari N, Joseph JP, Hussain SS, et al. Prevalence of human Papilloma virus sub genotypes following head and neck squamous cell carcinomas in Asian continent, A systematic review article[J]. Asian Pac J Cancer Prev, 2019, 20(11):3269-3277.
doi: 10.31557/APJCP.2019.20.11.3269 |
[21] |
Aghaeipour F, Salehiniya H, Abbaszadeh H. Prevalence of human papillomavirus (HPV) in oral mucosal lesions in Iran:A systematic review and meta-analysis[J]. J Med Virol, 2021, 93(11):6089-6099.
doi: 10.1002/jmv.27161 pmid: 34180541 |
[22] |
Giraldi L, Collatuzzo G, Hashim D, et al. Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer[J]. Cancer Epidemiol, 2021, 75:102020.
doi: 10.1016/j.canep.2021.102020 |
[23] |
Tumban E. A current update on human papillomavirus-associated head and neck cancers[J]. Viruses, 2019, 11(10):922.
doi: 10.3390/v11100922 |
[24] |
Gomez LM, Ma Y, HoC, et al. Placental infection with human papillomavirus is associated with spontaneous preterm delivery[J]. Hum Reprod, 2008, 23(3):709-715.
doi: 10.1093/humrep/dem404 |
[25] | Formánek M, Komínek P, Jančatová D, et al. Laryngopharyngeal reflux is a potential risk factor for juvenile-onset recurrent respiratory papillomatosis[J]. Biomed Res Int, 2019, 2019:1463896. |
[26] |
Quabius ES, Tribius S, Heinrichs A, et al. HPV DNA/RNA detection in various oral and oropharyngeal biomaterials identifies active HPV infections also in non-neoplastic tonsils[J]. Transl Oncol, 2021, 14(2):101002.
doi: 10.1016/j.tranon.2020.101002 |
[27] |
Pérez-González A, Cachay E, Ocampo A, et al. Update on the epidemiological features and clinical implications of human papillomavirus infection (HPV) and human immunodeficiency virus (HIV) coinfection[J]. Microorganisms, 2022, 10(5):1047.
doi: 10.3390/microorganisms10051047 |
[28] |
Minhas S, Kashif M, Rehman Z, et al. Molecular characterization and risk factors of oral high-risk human papillomavirus among females in Punjab, Pakistan[J]. J Med Virol, 2023, 95(1):e27893.
doi: 10.1002/jmv.v95.1 |
[29] |
Sethi S, Ju XQ, Antonsson A, et al. Oral HPV infection among indigenous australians; incidence, persistence, and clearance at 12-month follow-up[J]. Cancer Epidemiol Biomarkers Prev, 2022, 31(3):604-613.
doi: 10.1158/1055-9965.EPI-21-1056 |
[30] |
Drake VE, Fakhry C, Windon MJ, et al. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer[J]. Cancer, 2021, 127(7):1029-1038.
doi: 10.1002/cncr.33346 pmid: 33426652 |
[31] |
Zhang CT, Liu FF, Pan YQ, et al. Incidence and clearance of oral human papillomavirus infection:A population-based cohort study in rural China[J]. Oncotarget, 2017, 8(35):59831-59844.
doi: 10.18632/oncotarget.v8i35 |
[32] | 陈思凯, 史宏晖, 冷金花. 宫颈HPV感染与阴道内细菌微环境/免疫微环境的关系[J]. 生殖医学杂志, 2019, 28(6):711-716. |
[33] |
Cook RL, Thompson EL, Kelso NE, et al. Sexual behaviors and other risk factors for oral human papillomavirus infections in young women[J]. Sex Transm Dis, 2014, 41(8):486-492.
doi: 10.1097/OLQ.0000000000000159 pmid: 25013976 |
[34] |
Kiwerska K, Jozefiak A, Markowska J, et al. Oral-genital human papillomavirus infection in Polish couples:Frequent detection of HPV 42[J]. BMC Infect Dis, 2019, 19(1):122.
doi: 10.1186/s12879-018-3645-0 |
[35] |
Jordan KH, Beverly Hery CM, Zhang XC, et al. Low rates of dual-site and concordant oral-cervical human papillomavirus infections and cancers:A systematic review[J]. Front Oncol, 2022, 12:848628.
doi: 10.3389/fonc.2022.848628 |
[36] |
Nasioutziki M, Chatzistamatiou K, Loufopoulos PD, et al. Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy[J]. Infect Agent Cancer, 2020, 15:22.
doi: 10.1186/s13027-020-00287-7 |
[37] | Sánchez-Siles M, López-López AM, et al. Prevalence of human papillomavirus in the saliva of sexually active women with cervical intraepithelial neoplasias[J]. Med Oral Patol Oral Cir Bucal, 2020, 25(2):e195-e204. |
[38] |
Bordignon V, Di Domenico EG, Trento E, et al. How human papillomavirus replication and immune evasion strategies take advantage of the host DNA damage repair machinery[J]. Viruses, 2017, 9(12):390.
doi: 10.3390/v9120390 |
[39] |
Syrjänen S. Oral manifestations of human papillomavirus infections[J]. Eur J Oral Sci, 2018, 126(Suppl 1):49-66.
doi: 10.1111/eos.2018.126.issue-S1 |
[40] |
Della Fera AN, Warburton A, Coursey TL, et al. Persistent human papillomavirus infection[J]. Viruses, 2021, 13(2):321.
doi: 10.3390/v13020321 |
[41] |
Capaccia C, Diverio S, Zampini D, et al. The complex interaction between P53 and miRNAs joins new awareness in physiological stress responses[J]. Cells, 2022, 11(10):1631.
doi: 10.3390/cells11101631 |
[42] |
Li SY, Hong XL, Wei ZT, et al. Ubiquitination of the HPV oncoprotein E6 is critical for E6/E6AP-mediated p53 degradation[J]. Front Microbiol, 2019, 10:2483.
doi: 10.3389/fmicb.2019.02483 pmid: 31749782 |
[43] |
Zhou CH, Tuong ZK, Frazer IH. Papillomavirus immune evasion strategies target the infected cell and the local immune system[J]. Front Oncol, 2019, 9:682.
doi: 10.3389/fonc.2019.00682 pmid: 31428574 |
[44] |
James CD, Saini S, Sesay F, et al. Restoring the DREAM complex inhibits the proliferation of high-risk HPV positive human cells[J]. Cancers, 2021, 13(3):489.
doi: 10.3390/cancers13030489 |
[45] |
Timbang MR, Sim MW, Bewley AF, et al. HPV-related oropharyngeal cancer:A review on burden of the disease and opportunities for prevention and early detection[J]. Hum Vaccin Immunother, 2019, 15(7/8):1920-1928.
doi: 10.1080/21645515.2019.1600985 |
[46] | 王艺如. 宫颈癌预防研究现状与HPV疫苗的研究进展[J]. 中国处方药, 2021, 19(8):17-18. |
[47] |
Herrero R, Quint W, Hildesheim A, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica[J]. PLoS One, 2013, 8(7):e68329.
doi: 10.1371/journal.pone.0068329 |
[48] |
Lehtinen M, Apter D, Eriksson T, et al. Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial[J]. Int J Cancer, 2020, 147(1):170-174.
doi: 10.1002/ijc.32791 pmid: 31736068 |
[49] |
Browne S, Feemster KA. Human papillomavirus:Optimizing opportunities for prevention[J]. Curr Opin Pediatr, 2022, 34(2):132-139.
doi: 10.1097/MOP.0000000000001119 pmid: 35152231 |
[50] |
Oshman LD, Davis AM. Human papillomavirus vaccination for adults:updated recommendations of the Advisory Committee on Immunization Practices (ACIP)[J]. JAMA, 2020, 323(5):468-469.
doi: 10.1001/jama.2019.18411 |
[51] |
Zhang X, Chen H, Zhou J, et al. Impact of web-based health education on HPV vaccination uptake among college girl students in Western and Northern China:A follow-up study[J]. BMC Womens Health, 2022, 22(1):46.
doi: 10.1186/s12905-022-01625-0 pmid: 35197068 |
[52] |
Ma XM, Wang Q, Ong JJ, et al. Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China:A systematic review and meta-analysis[J]. Sex Transm Infect, 2018, 94(6):434-442.
doi: 10.1136/sextrans-2017-053412 |
[53] |
Hashim D, Genden E, Posner M, et al. Head and neck cancer prevention:From primary prevention to impact of clinicians on reducing burden[J]. Ann Oncol, 2019, 30(5):744-756.
doi: S0923-7534(19)31170-6 pmid: 31987341 |
[54] |
Wierzbicka M, Klussmann JP, San Giorgi MR, et al. Oral and laryngeal HPV infection:Incidence, prevalence and risk factors, with special regard to concurrent infection in head, neck and genitals[J]. Vaccine, 2021, 39(17):2344-2350.
doi: 10.1016/j.vaccine.2021.03.047 |
[55] |
Day AT, Fakhry C, Tiro JA, et al. Considerations in human papillomavirus-associated oropharyngeal cancer screening:A review[J]. JAMA Otolaryngol Head Neck Surg, 2020, 146(7):656-664.
doi: 10.1001/jamaoto.2019.4811 |
[56] | 周曾同. 人乳头瘤病毒感染与口腔黏膜疾病[J]. 口腔医学, 2015, 35(12),993-998. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||